SCHEMBL4934374

SCHEMBL4934374

Cc1cc2nc(CC[C@H](N)C(=O)NO)n(-c3ccc(F)cc3)c2cc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ MCHR1 Q99705 4/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ GFER P55789 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ PTGES O14684 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34
▸ NTRK1 P04629 1/20 0.34
▸ NTRK2 Q16620 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4934387 1.00 HDAC6 (0.37) HDAC6PDE10AMCHR1KMT2AGFER
SCHEMBL4935414 0.92 NTRK1 (0.41) HDAC6PDE10AKMT2AKDM4EPOLB
SCHEMBL4935437 0.92 NTRK1 (0.41) HDAC6PDE10AKMT2AKDM4EPOLB
SCHEMBL4936237 0.92 NTRK1 (0.41) HDAC6PDE10AKMT2AKDM4EPOLB
SCHEMBL4933134 0.89 NTRK1 (0.44) HDAC6PDE10AKMT2AHDAC1POLB
SCHEMBL4932046 0.89 NTRK1 (0.44) HDAC6PDE10AKMT2AHDAC1POLB
SCHEMBL4932064 0.89 NTRK1 (0.44) HDAC6PDE10AKMT2AHDAC1POLB
SCHEMBL4931996 0.88 KDM4E (0.41) HDAC6PDE10AKMT2AHDAC1KDM4E
SCHEMBL4932009 0.88 KDM4E (0.41) HDAC6PDE10AKMT2AHDAC1KDM4E
SCHEMBL4936172 0.84 AGTR1 (0.46) KMT2APOLBRAB9AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 — — US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 HDAC6 10/4885PDE10A 1467/4885MCHR1 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback